best performing large cap stocks between apr 2012 to oct 2013

QXO (QXO) had the highest return between April 1, 2012 and October 31, 2013 by a large-cap US stock, returning 6,720,200%.

ASSETDATE% RETURN
QXO (QXO)
4/1/2012 - 10/31/2013
6,720,200%
Genmab A-S (GMAB)
4/1/2012 - 10/31/2013
563%
Alnylam Pharmaceuticals (ALNY)
4/1/2012 - 10/31/2013
421.36%
Tesla (TSLA)
4/1/2012 - 10/31/2013
328.44%
Axon Enterprise (AXON)
4/1/2012 - 10/31/2013
308.74%
Insmed (INSM)
4/1/2012 - 10/31/2013
292.29%
Generac (GNRC)
4/1/2012 - 10/31/2013
207.07%
Corpay (CPAY)
4/1/2012 - 10/31/2013
205.24%
Gilead Sciences (GILD)
4/1/2012 - 10/31/2013
192.26%
Diamondback Energy (FANG)
4/1/2012 - 10/31/2013
189.84%
Saia (SAIA)
4/1/2012 - 10/31/2013
186.86%
Netflix (NFLX)
4/1/2012 - 10/31/2013
180.91%
DexCom (DXCM)
4/1/2012 - 10/31/2013
177.58%
Constellation Brands Inc Class A (STZ)
4/1/2012 - 10/31/2013
177.52%
Apollo Global Management LLC Class A (APO)
4/1/2012 - 10/31/2013
170.53%
Cheniere Energy (LNG)
4/1/2012 - 10/31/2013
168.19%
Delta Air Lines (DAL)
4/1/2012 - 10/31/2013
167.77%
Smurfit WestRock (SW)
4/1/2012 - 10/31/2013
159.8%
CoStar (CSGP)
4/1/2012 - 10/31/2013
157.48%
Tyler Technologies (TYL)
4/1/2012 - 10/31/2013
151.65%
Trip Group Ltd ADR (TCOM)
4/1/2012 - 10/31/2013
150.02%
Everpure (P)
4/1/2012 - 10/31/2013
146.13%
Regeneron Pharmaceuticals (REGN)
4/1/2012 - 10/31/2013
144.85%
Lloyds Banking Group PLC ADR (LYG)
4/1/2012 - 10/31/2013
141.83%
West Pharmaceutical Services (WST)
4/1/2012 - 10/31/2013
133.22%
Large-cap stocks are treated as having a market cap of $10B+.